ArticleInternational journal of molecular sciences2022
Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 19 Deletion, T790M, and cis-C797S Triple Mutations: A Case Report.
Zi-Wei Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.